Citigroup’s BioCardia BCDA Stock Holding History

Citigroup’s Portfolio BCDA Stock Details BCDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$493K	Buy	+397,594	New	+$419K	﹤0.01%	3906
2025 Q4	–	Sell	-833	Closed	-$1.07K	–	6081
2025 Q3	$1.07K	Buy	+833	New	+$1.63K	﹤0.01%	5616

Other funds holding BCDA

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Pingora Partners Wilson, Wyoming $171M AUM 60.67% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Citigroup's BCDA Position: Q2 2026 in Review

Citigroup opened a new position in BioCardia (BCDA) in Q2 2026: 397,594 shares worth $493K. The stake represents ﹤0.01% of the portfolio and ranks #3906 among its holdings. This is a return to the name: Citigroup previously reported a position in BCDA as recently as Q3 2025.

Citigroup first reported a position in BCDA in Q3 2025 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

Citigroup held 397,594 shares of BioCardia worth $493K as of Q2 2026.
BioCardia was a new Citigroup position in Q2 2026.
BioCardia made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3906 holding.
Citigroup first reported a position in BioCardia in Q3 2025 and has held it in 2 quarters since.
21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.